Merck's new 2-drug HIV pill wins FDA approval as alternative to 3-drug regimens Apr 22, 2026 · Colleen Cabili Idvynso combines doravirine and islatravir in a once-daily tablet cleared for adults already suppressing HIV on stable therapy Read more »
.jpg?branch=production&format=jpg&width=1024)
.png?branch=production&format=jpg&width=1024)
